Company intelligence / Profile preview

Aderans Research Institute

Ownership: Private
Development stage: Other

Overview

Aderans Research Institute developed a cell therapy and tissue engineering approach for hair regeneration. Their lead program reached Phase 2 clinical trials in the U.S., focusing on using autologous fibroblasts and keratinocytes to regenerate hair follicles in patients with pattern baldness. The technology aimed to offer a regenerative solution for both men and women suffering from androgenetic alopecia, as well as those who lost hair due to injury or disease. No recent updates indicate further progression beyond Phase 2 or commercial launch.[7][8]

Therapeutic areas: Dermatology
Modalities: Cell therapyTissue engineering
Industry: Biotech

Drug pipeline

2 assets

Ji Gami

1 more asset in the full pipeline.

Request access →

Partnerships

Bosley Medical Institute

Beyond the preview

Go deeper on Aderans Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aderans Research Institute.

Explore the full profile